JP2024534567A5 - - Google Patents

Info

Publication number
JP2024534567A5
JP2024534567A5 JP2024518351A JP2024518351A JP2024534567A5 JP 2024534567 A5 JP2024534567 A5 JP 2024534567A5 JP 2024518351 A JP2024518351 A JP 2024518351A JP 2024518351 A JP2024518351 A JP 2024518351A JP 2024534567 A5 JP2024534567 A5 JP 2024534567A5
Authority
JP
Japan
Prior art keywords
methyl
piperidyl
pyridine
pyridyl
piperazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024518351A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534567A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/076306 external-priority patent/WO2023046806A1/en
Publication of JP2024534567A publication Critical patent/JP2024534567A/ja
Publication of JP2024534567A5 publication Critical patent/JP2024534567A5/ja
Pending legal-status Critical Current

Links

JP2024518351A 2021-09-24 2022-09-22 自己免疫疾患の処置のためのピラゾロ[3,4-b]ピリジン化合物 Pending JP2024534567A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN2021120406 2021-09-24
CNPCT/CN2021/120406 2021-09-24
CN2022089033 2022-04-25
CNPCT/CN2022/089033 2022-04-25
PCT/EP2022/076306 WO2023046806A1 (en) 2021-09-24 2022-09-22 Pyrazolo[3,4-b]pyridine compounds for the treatment of autoimmune disease

Publications (2)

Publication Number Publication Date
JP2024534567A JP2024534567A (ja) 2024-09-20
JP2024534567A5 true JP2024534567A5 (cg-RX-API-DMAC10.html) 2025-09-26

Family

ID=83688579

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024518351A Pending JP2024534567A (ja) 2021-09-24 2022-09-22 自己免疫疾患の処置のためのピラゾロ[3,4-b]ピリジン化合物

Country Status (16)

Country Link
US (1) US20240360126A1 (cg-RX-API-DMAC10.html)
EP (1) EP4405051B1 (cg-RX-API-DMAC10.html)
JP (1) JP2024534567A (cg-RX-API-DMAC10.html)
KR (1) KR20240065092A (cg-RX-API-DMAC10.html)
CN (1) CN118076604A (cg-RX-API-DMAC10.html)
AR (1) AR127126A1 (cg-RX-API-DMAC10.html)
AU (1) AU2022351495A1 (cg-RX-API-DMAC10.html)
CA (1) CA3228485A1 (cg-RX-API-DMAC10.html)
CL (1) CL2024000791A1 (cg-RX-API-DMAC10.html)
CO (1) CO2024003401A2 (cg-RX-API-DMAC10.html)
CR (1) CR20240134A (cg-RX-API-DMAC10.html)
IL (1) IL310443A (cg-RX-API-DMAC10.html)
MX (1) MX2024003444A (cg-RX-API-DMAC10.html)
PE (2) PE20250401A1 (cg-RX-API-DMAC10.html)
TW (1) TW202328129A (cg-RX-API-DMAC10.html)
WO (1) WO2023046806A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026515029A (ja) * 2023-04-28 2026-05-13 成都思倍博医▲薬▼科技有限公司 オキソピリド脂肪族環又は脂肪族複素環構造を含む化合物及びその医学的使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9643967B2 (en) * 2013-12-13 2017-05-09 Takeda Pharmaceutical Company Limited Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors
EP4059934B1 (en) 2016-09-09 2026-07-29 Novartis AG Compounds and compositions as inhibitors of endosomal toll-like receptors
JP2021507889A (ja) * 2017-12-22 2021-02-25 ノバルティス アーゲー ピラゾロピペリジン誘導体の新規な使用
WO2019220390A1 (en) 2018-05-18 2019-11-21 Novartis Ag Crystalline forms of a tlr7/tlr8 inhibitor
CN112752755A (zh) * 2018-09-27 2021-05-04 豪夫迈·罗氏有限公司 用于治疗自身免疫性疾病的杂环基化合物
JP2023533807A (ja) * 2020-07-14 2023-08-04 エフ. ホフマン-ラ ロシュ アーゲー 自己免疫疾患の処置のためのヒドロイソキノリン又はヒドロナフチリジン化合物

Similar Documents

Publication Publication Date Title
AU2023266254B2 (en) Bifunctional compounds for degrading btk via ubiquitin proteosome pathway
CN116368140A (zh) 杂环glp-1激动剂
JP2025078673A (ja) インダゾール系化合物及び関連使用方法
RU2018123825A (ru) Соединения и способы для модуляции киназ, и показания для этого
JP2012503018A5 (cg-RX-API-DMAC10.html)
JP6117235B2 (ja) Pi3kの活性または機能の阻害剤の使用
CA3139019A1 (en) Amino quinazoline derivatives as p2x3 inhibitors
AU2018390610A1 (en) Amino indole compounds useful as TLR inhibitors
JP2023539663A (ja) 急速進行性線維肉腫タンパク質分解化合物及び関連する使用方法
JP2015510938A5 (cg-RX-API-DMAC10.html)
JP2012525395A5 (cg-RX-API-DMAC10.html)
US10526323B2 (en) Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
KR20030016283A (ko) 뉴로키닌 수용체 길항제로서의1,3,8-트리아자-스피로[4.5]데칸-4-온 유도체
JP2011515462A5 (cg-RX-API-DMAC10.html)
AU2021242143B2 (en) Aminopyrimidine derivatives and their use as Aryl hydrocarbon receptor modulators
CN102482256B (zh) N-取代的环状氨基衍生物
RU2006100190A (ru) Производные хинолиламида в качестве антагонистов ccr-5
CN114907338B (zh) 含氮多环稠环类化合物,其药物组合物、制备方法和用途
JPWO2019216294A5 (cg-RX-API-DMAC10.html)
KR20230051500A (ko) Alk5 억제제로서 피리다진일 아미노 유도체
JP2023510971A (ja) 新規複素環式化合物
JP2025509895A (ja) Teaドメインファミリーメンバーの小分子阻害薬
JP2025513019A5 (cg-RX-API-DMAC10.html)
JP2023533807A5 (cg-RX-API-DMAC10.html)
JP2013522372A5 (cg-RX-API-DMAC10.html)